[c09aa8]: / clusters / 9knumclustersv2 / clust_1146.txt

Download this file

48 lines (47 with data), 3.5 kB

 1
 2
 3
 4
 5
 6
 7
 8
 9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
No patients that are known to be pregnant or nursing
Patients who are pregnant or actively nursing an infant are not eligible
Patients who are pregnant or nursing
Patients who are pregnant or nursing.
Patients must not be pregnant or nursing
Subjects must not be pregnant or nursing due to the potential for congenital abnormalities and the potential of this regimen to harm nursing infants.
Subjects must not be pregnant or nursing due to the potential for congenital abnormalities and the potential of this regimen to harm nursing infants
Non-pregnant and non-nursing; pregnant and nursing patients may not be enrolled; women and men of reproductive potential must agree to use acceptable forms of contraception during the study
Patients who are pregnant or nursing
Patients who are pregnant or nursing
Pregnant or nursing patients
PHASE I: Patients must not be pregnant or nursing as the potential of this regimen to harm nursing infants has not been evaluated
PHASE II: Patients must not be pregnant or nursing as the potential of this regimen to harm nursing infants has not been evaluated
Subjects must not be pregnant or nursing due to the potential for congenital abnormalities and the potential of this regimen to harm nursing infants.
Patients who are pregnant or nursing
Patients who are pregnant or nursing
Pregnant or nursing patients
Patients who are pregnant or nursing
Patients who are pregnant or nursing
Patient must not be pregnant because of the risk of harm to the fetus; nursing women may participate only if nursing is discontinued, due to the possibility of harm to nursing infants from the treatment regimen; women/men of reproductive potential must agree to use an effective contraception method
Patients must not be pregnant or nursing due to the potential for congenital abnormalities and the potential of this regimen to harm nursing infants
Patients must not be nursing due to the potential for congenital abnormalities and the potential of this regimen to harm nursing infants
Patients must not be pregnant or nursing
Patients must not be pregnant or nursing
Patients who are pregnant or nursing
Patients of childbearing potential, not practicing adequate contraception, patients who are pregnant or patients who are nursing are not eligible for this trial; bevacizumab should not be administered to nursing women
Patients who are pregnant or nursing
Patients must be non-pregnant and non-nursing
Patients who are pregnant or nursing
Patients who are pregnant or nursing
Patients who are pregnant or nursing
Patients who are pregnant or nursing are not eligible
Patients pregnant or nursing
Non-pregnant and non-nursing; pregnant or nursing patients may not be enrolled; women and men of reproductive potential should agree to use an effective means of birth control
Patients who are pregnant or nursing
Patients who are pregnant or nursing.
Patients who are pregnant, nursing, or who wish to become pregnant during the study
Patients who are pregnant or nursing
Patients must not be pregnant or nursing
Patients must not be pregnant or nursing
Patients who are pregnant or nursing
Patients who are pregnant or nursing are ineligible
No exclusion criteria for pregnant or nursing patients from participating in this study (of note, pregnant patients will not be treated with vaginal brachytherapy, a requirement for enrolling on this study)
Pregnant or nursing patients will not be included in the study
Patients who are pregnant or nursing
Pregnancy or nursing patients
Known pregnant or nursing patients